We recently published a list of the 10 Innovative Healthcare Stocks to Watch in 2025. In this article, we are going to take a ...

BigHat Biosciences, a biotechnology company, has entered a strategic collaboration with Eli Lilly and Company.

BigHat Biosciences ("BigHat"), a biotechnology company with a machine learning (ML)-guided antibody discovery and development platform, announced a strategic collaboration with Eli Lilly and Company ( ...

US biotech Grove Biopharma has secured $30 million in a series A round to move its lead program targeting advanced prostate ...

Carlo Rizzuto, managing director of Versant Ventures, spoke on CNBC’s “Fast ... by 218 percentage points (see more details here). Eli Lilly and Company (NYSE:LLY), a global pharmaceutical ...

Eli Lilly and Co. aired positive top-line data from the phase III trial called Achieve-1 testing orforglipron vs. placebo in adults with type 2 diabetes and inadequate glycemic control with diet and ...

Northwestern University spinout Grove Biopharma, a synthetic biology specialist developing a platform known as Bionic ...

Duyk said the $30 million in funding has helped Grove Biopharma expand from "about four people working on this" to a current 10-person headcount and allowed it to move from Portal Innovations' labs to ...